Abstract
Two clinical strains of Klebsiella pneumoniae (K. pneumoniae) and one isolate of Escherichia coli (E. coli) were collected from two large general hospitals in China. Conjugation experiment, susceptibility testing, isoelectric focusing, PCR, and sequencing techniques as well as clone, expression, purification and kinetics were carried out to describe the characterization of the novel SHV-tpye enzyme. The analysis of plasmid profiling and pulsed-field gel electrophoresis of the novel enzyme were performed to investigate epidemiology. These isolates had CTX-M-14 and SHV-89 β-lactamases. SHV-89 β-lactamase of pI 7.6 is a novel variant with two substitutions compared with the sequence of SHV-1: Leu35Gln and Met129Val. Its gene also had two silent mutations at positions 369 and 774, respectively. The results of substrate profiles and MIC determinations showed the activity of the novel enzyme was insufficient for the enzyme to count as an extended-spectrum β-lactamase (ESBL). The substrates of the enzyme were also characterized. Furthermore, the three novel SHV enzyme-producing strains were epidemiologically unrelated. The emergence of a novel SHV-type β-lactamase is rarely described in other areas. This study illustrates the importance of molecular survelliance in tracking SHV-producing strains in large teaching hospitals and emphasizes the need for epidemiological monitoring.
Similar content being viewed by others
References
Chang FY, Siu LK, Fung CP, Huang MH, Ho M (2001) Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26. Antimicrob Agents Chemother 45:2407–2413
Bradford PA (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14:933–951
Ling BD, Liu G, Xie YE, Zhou QX, Zhao TK, Li CQ, Yu X, Lei J (2006) Characterisation of a novel extended-spectrum beta-lactamase, SHV-70, from a clinical isolate of Enterobacter cloacae in China. Int J Antimicrob Agents 27:355–356
Ma L, Jimena A, Feng-Yee C, Masaji I, Keizo Y, Siu LK, Yoshikazu I (2005) Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin. Antimicrob Agents Chemother 49:600–605
Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B (1985) Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 28:302–307
Liebana E, Gibbs M, Clouting C, Barker L, Clifton-Hadley FA, Pleydell E, Abdalhamid B, Hanson ND, Martin L, Poppe C, Davies RH (2004) Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom. Microb Drug Resist 10:1–9
Clinical and Laboratory Standards Institute/NCCLS (2005) Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. CLSI/NCCLS document M100-S15 25:1–167
Stürenburg E, Kühn A, Mack D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M (2004) A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance. J Antimicrob Chemother 54:406–409
Bou G, Martínez-Beltrán J (2000) Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 44:428–432
Nagano N, Nagano Y, Cordevant C, Shibata N, Arakawa Y (2004) Nosocomial transmission of CTX-M-2 beta-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol 42:3978–3984
Ishii Y, Ohno A, Taguchi H, Imajo S, Ishiguro M, Matsuzawa H (1995) Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli. Antimicrob Agents Chemother 39:2269–2275
Bonnet R, Dutour C, Sampaio JL, Chanal C, Sirot D, Labia R, De Champs C, Sirot J (2001) Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob Agents Chemother 45:2269–2275
Pechère JC, Guay R, Dubois J, Letarte R (1980) Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilis. Antimicrob Agents Chemother 17:1001–1003
Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233–2239
Machado E, Cantón R, Baquero F, Galán JC, Rollán A, Peixe L, Coque TM (2005) Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid, Spain. Antimicrob Agents Chemother 49:1823–1829
Yuan M, Hall LM, Savelkoul PH, Vandenbroucke-Grauls CM, Livermore DM (2000) SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam. Antimicrob Agents Chemother 44:1081–1084
Naas T, Philippon L, Poirel L, Ronco E, Nordmann P (1999) An SHV-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother 43:1281–1284
Pitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Coudron P, Sanders CC (1998) Plasmid-mediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strains. Antimicrob Agents Chemother 42:596–600
Park YJ, Yu JK, Lee S, Oh EJ, Woo GJ (2007) Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea. J Antimicrob Chemother 60:868–871
Majtan T, Majtanova L, Timko J, Majtan V (2007) Oligonucleotide microarray for molecular characterization and genotyping of Salmonella spp. strains. J Antimicrob Chemother 60:937–946
Biendo M, Canarelli B, Thomas D, Rousseau F, Hamdad F, Adjide C, Laurans G, Eb F (2008) Successive emergence of extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital. J Clin Microbiol 46:1037–1044
Roh KH, Uh Y, Kim JS, Kim HS, Shin DH, Song W (2008) First outbreak of multidrug-resistant Klebsiella pneumoniae producing both SHV-12-type extended-spectrum beta-lactamase and DHA-1-type AmpC beta-lactamase at a Korean hospital. Yonsei Med J 49:53–57
Bush K (2008) Extended-spectrum beta-lactamases in North America, 1987–2006. Clin Microbiol Infect 14(Suppl 1):134–143
Machado E, Coque TM, Cantón R, Novais A, Sousa JC, Baquero F, Peixe L, Portuguese Resistance Study Group (2007) High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 60:1370–1374
Cobo J, Morosini MI, Pintado V, Tato M, Samaranch N, Baquero F, Cantón R (2008) Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta-lactamase-producing Klebsiella pneumoniae epidemic clone. Diagn Microbiol Infect Dis 60:319–322
Jacoby GA (1998) Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis 27:76–80
Chaves J, Ladona MG, Segura C, Coira A, Reig R, Ampurdanés C (2001) SHV-1 beta-lactamase is mainly a chromosomally encoded species-specific enzyme in Klebsiella pneumoniae. Antimicrob Agents Chemother 45:2856–2861
Xiong Z, Zhu D, Wang F, Zhang Y, Okamoto R, Inoue M (2004) A Klebsiella pneumoniae producing three kinds of class A beta-lactamases encoded by one single plasmid isolated from a patient in Huashan Hospital, Shanghai, China. Int J Antimicrob Agents 23:262–267
Pitout JD, Sanders CC, Sanders WE Jr (1997) Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am J Med 103:51–59
Bush K (2001) New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 32:1085–1089
Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, Mariano N, Marks S, Burns JM, Dominick D, Lim M (1998) Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA 280:1233–1237
Pitout JD, Gregson DB, Church DL, Elsayed S, Laupland KB (2005) Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region. J Clin Microbiol 43:2844–2849
Acknowledgement
This study is supported by National Natural Science Foundation of China (No.30571654).
Author information
Authors and Affiliations
Corresponding authors
Additional information
J.-B. Li and J. Cheng contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, JB., Cheng, J., Wang, Q. et al. A novel SHV-type β-lactamase variant (SHV-89) in clinical isolates in China. Mol Biol Rep 36, 1141–1148 (2009). https://doi.org/10.1007/s11033-008-9290-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-008-9290-8